We here at WorldNetDaily need your help. For nearly 30 years, WND has delivered independent investigative reporting that others won’t touch. Watching, subscribing and commenting on Rumble is one of the most important ways you can help us continue that work and expand its reach. It only takes a moment, but it makes a real difference in keeping this reporting visible and strong. Thank you!
What if two cheap, widely available drugs could become powerful weapons against cancer, and the medical establishment simply isn’t looking hard enough?
New research involving ivermectin and mebendazole is producing results that demand attention. In a study of 200 cancer patients, researcher Nicolas Hulscher reports that 84.4% experienced clinical benefit, with more than 30% classified as having no evidence of disease after six months. The findings are preliminary and require large randomized clinical trials, but Hulscher says the signal is the strongest researchers have yet observed in humans.
In this explosive conversation, Elizabeth Farah and Hulscher dig into what these drugs may actually be doing to cancer cells, why inexpensive generic treatments struggle to attract the enormous funding required for major clinical trials, and whether ivermectin’s demonization during COVID helped bury research that should have been pursued years ago.
And cancer is only part of the story. Hulscher reveals his alarming reanalysis of FDA data behind Moderna’s new mRNA flu vaccine and discusses research comparing fully vaccinated and completely unvaccinated children. The numbers raise profound questions about vaccine safety, pharmaceutical influence, government regulators, and whether Americans are finally beginning to challenge a medical establishment they once trusted without question.
If Hulscher’s cancer findings hold up under rigorous clinical testing, the implications could be enormous. The question now is whether anyone with the resources to find out is willing to do it.
Join the discussion on X:
🚨 WHAT IF THEY’VE HAD IT ALL ALONG? 84% of cancer patients benefited while taking ivermectin + mebendazole. Nicolas Hulscher reveals the stunning study. @NicHulscher https://t.co/VTcgWG0mMS
— Elizabeth Farah 🇺🇸 America 1st always 🇮🇱 (@ElizabethFarah) August 24, 2026
Here are the links to watch the Elizabeth Farah Show interviews on various platforms:
Elizabeth Farah on YouTube
Elizabeth Farah on X
WND on X
Elizabeth Farah on Rumble
